Assyro AI

Orange Book product · Brand (NDA)

ESKATA

HYDROGEN PEROXIDE

Brand (NDA)NDA 209305DISCN ACLARIS

At a glance

Dec 14, 2017

Approved

Brand (NDA)

Application

Not listed

TE code

5

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 14, 2017

    8 yr 8 mo ago

  2. Today

  3. Patent 10098910 expires

    Listed drug product patent expiration.

    Apr 21, 2035

    in 9 yr

  4. Patent 10493103 expires

    Listed drug product patent expiration.

    Apr 21, 2035

    in 9 yr

  5. Patent 10729720 expires

    Listed drug product patent expiration.

    Apr 21, 2035

    in 9 yr

  6. Patent 9980983 expires

    Listed method-of-use patent (U-2205) expiration.

    Apr 21, 2035

    in 9 yr

  7. Patent 9675639 expires

    Listed drug product patent expiration.

    Jul 04, 2035

    in 9 yr 2 mo

Pharmaceutical detail

Active ingredient

HYDROGEN PEROXIDE

Strength

40%

Dosage form

SOLUTION

Route

TOPICAL

TE code

Not listed

Application

NDA 209305

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (5)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10098910Apr 21, 2035in 9 yr
ProductU-2205
10493103Apr 21, 2035in 9 yr
Product
10729720Apr 21, 2035in 9 yr
Product
9980983Apr 21, 2035in 9 yr
U-2205
9675639Jul 04, 2035in 9 yr 2 mo
ProductU-2205
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.